REAKSI Drug Safety News

Reaksi Drug Safety News 2017 - Issue 6/2017

Written by Jauze · 7 December 2017

Reaksi Drug Safety News 2017,

Issue 6/2017

 

  • Ketamine: Risk of Severe Liver Damage with Repeated and/or Prolonged Use at High Doses
  • Recombinant Human Erythropoietins: Risk of Severe Cutaneous Adverse Reactions (SCARs)

 

 

  
  DOWNLOAD PDF

 

 

 


  Reaksi Archive

Rate this page

Not yet rated

Share on Facebook Share on X Share on WhatsApp Share on LinkedIn
Page tools
Email
All publications